Fresh Rounds

Verra Therapeutics, Inc. funding

Verra Therapeutics, Inc., a biotechnology company based in Lansing, NY (founded 2024), filed a Form D with the SEC on February 18, 2026 and reported $205K raised of a $450K offering.

Amount raised$205K
Offering size$450K
Filed with the SECFebruary 18, 2026
First saleDecember 16, 2024
IndustryBiotechnology
SecuritiesEquity
LocationLansing, NY
Founded2024
Entity typeCorporation
Investors so far6
Minimum investment$10K
Revenue range$1 - $1,000,000

Other health care rounds in New York